<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00253916</url>
  </required_header>
  <id_info>
    <org_study_id>NCIC 013232</org_study_id>
    <secondary_id>OTT 02-04</secondary_id>
    <secondary_id>CERHO 2002263-01H</secondary_id>
    <nct_id>NCT00253916</nct_id>
  </id_info>
  <brief_title>Exercise in Men Receiving Radiation Therapy for Prostate Cancer.</brief_title>
  <official_title>Exercise in Men Receiving Radiation Therapy for Prostate Cancer: Effects on Fatigue, Toxicity, Body Composition, Muscular Fitness, Cardiorespiratory Fitness and Quality of Life.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Cancer Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <brief_summary>
    <textblock>
      Androgen Deprivation Therapy is a commonly used treatment for men with Prostate Cancer.
      Unfortunately this can lead to functional decline, fatigue, increased body fatness, loss of
      lean body tissue and impaired QOL. Previous research has demonstrated the exercise can may
      reduce fatigue and improve QOL in men on ADT. This study will evaluate whether aerobic versus
      resistance exercise over a 24 week period of training will reduce morbidity and improve QOL
      in men receiving radiation plus or minus ADT with curative intent
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 220 men with a diagnosis of prostate cancer, scheduled to receive radiation will
      be recruited. The study is a parallel 3-group design with groups stratified for intended
      duration of ADT ( greater or less than 12 weeks) and random assignment to aerobic, resistance
      or Wait List control groups. The dependent variable of interest will fatigue measured at 24
      weeks by the 13 item FACT-Fatigue. Dependent variables of secondary interest will be toxicity
      of radiation, body composition, muscular fitness, cardio-respiratory fitness, metabolic
      fitness, and prostate specific QOL. All exercise sessions will be performed 3 times per week
      at the Ottawa Hospital regional Cancer Center
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2002</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fatigue- FACT F</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Toxicity of Radiotherapy Body Composition Muscular Fitness Cardiorespiratory Fitness Metabolic Fitness Prostate Specific QOL</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">121</enrollment>
  <condition>Prostatic Neoplasms</condition>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No exercise measured</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobic cardiovascular exercise program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aerobic cardiovascular exercise program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance Exercise Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Resistance Exercise Program</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Aerobic cardiovascular exercise program</intervention_name>
    <description>Aerobic cardiovascular exercise program</description>
    <arm_group_label>Aerobic cardiovascular exercise program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Resistance Exercise Program</intervention_name>
    <description>Resistance Exercise Program</description>
    <arm_group_label>Resistance Exercise Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Prostate Cancer

          -  Radiation Therapy with curative Intent

          -  ADT

        Exclusion Criteria:

          -  Contraindication to exercise

          -  Uncontrolled hypertension

          -  Uncontrolled Cardiac Disease

          -  Uncontrolled psychotic condition

          -  Unable to obtain informed consent
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roanne Segal</last_name>
    <role>Principal Investigator</role>
    <affiliation>OHRI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ottawa Hospital-Integrated Cancer Program</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H-1C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003 May 1;21(9):1653-9.</citation>
    <PMID>12721238</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2005</study_first_submitted>
  <study_first_submitted_qc>November 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2005</study_first_posted>
  <last_update_submitted>May 9, 2017</last_update_submitted>
  <last_update_submitted_qc>May 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

